Chi Lin, MD, PhD

Trials

Studies that name Chi Lin, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:52 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT05254327 · Trial of the Efficacy and Safety of Short and Long Course Radiation Therapy With/Without BMX-001

  University of Nebraska · recruiting · Rectal Cancer · principal investigator
• Ph1
  NCT03256331 · Evaluate the Safety of BEL-X-HG in Advanced Cancer Patients

  Belx Bio-Pharmaceutical (Taiwan) Corporation · terminated · Advanced Solid Tumors · principal investigator
• Ph2
  NCT03073785 · Hypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic Cancer

  University of Nebraska · active not recruiting · Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage I Pancreatic Cancer AJCC v6 and v7 · principal investigator
• N/A
  NCT00607828 · Stereotactic Radiation Therapy in Treating Patients With Advanced Liver Cancer

  University of Nebraska · completed · Liver Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Buffett Cancer Center Support Grant
  P30CA036727 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Joann B. Sweasy · fiscal years 1985 to 2026
  Named on NCT03073785, NCT00607828